메뉴 건너뛰기




Volumn 9, Issue 3, 2006, Pages 395-402

Evaluation of an alternative dosing regimen with tadalafil, three times per week, for men with erectile dysfunction: SURE study in Italy

(99)  Mirone, Vincenzo a   Imbimbo, Ciro a   Rossi, Andrea b   Sicuteri, Riccardo b   Valle, Domenico b   Longo, Nicola c   Fusco, Ferdinando a   Alei, G c   Anselmo, G c   Aquilini, M c   Bellorofonte, C c   Bonno, A c   Boscaro, M c   Bozzo, W c   Breda, G c   Caotorta, M M c   Carani, C c   Casarico, A c   Cassutti, V c   Cecchi, M c   more..


Author keywords

Alternate; Erectile dysfunction; On demand; SURE study; Tadalafil; Three times per week

Indexed keywords

TADALAFIL; CARBOLINE DERIVATIVE; PHOSPHODIESTERASE INHIBITOR;

EID: 34347252698     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1111/j.1745-7262.2007.00214.x     Document Type: Article
Times cited : (8)

References (10)
  • 1
    • 0038353576 scopus 로고    scopus 로고
    • Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: A randomized controlled trial
    • Porst H, Padma-Nathan H, Giuliano F, Anglin G, Varanese L, Rosen R. Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: A randomized controlled trial. Urology 2003; 62: 121-5.
    • (2003) Urology , vol.62 , pp. 121-125
    • Porst, H.1    Padma-Nathan, H.2    Giuliano, F.3    Anglin, G.4    Varanese, L.5    Rosen, R.6
  • 2
    • 0036197133 scopus 로고    scopus 로고
    • IC351 (tadalafil, Cialis): Update on clinical experience
    • Porst H. IC351 (tadalafil, Cialis): Update on clinical experience. Int J Impot Res 2002; 14 (Suppl 1): S57-64.
    • (2002) Int J Impot Res , vol.14 , Issue.SUPPL. 1
    • Porst, H.1
  • 3
    • 21144476846 scopus 로고    scopus 로고
    • An evaluation of an alternative dosing regimen with tadalafil, 3 times/ week, for men with erectile dysfunction: SURE study in 14 European countries
    • Mirone V, Costa P, Damber JE, Holmes S, Moncada I, Van Ahlen H, et al. An evaluation of an alternative dosing regimen with tadalafil, 3 times/ week, for men with erectile dysfunction: SURE study in 14 European countries. Eur Urol 2005; 47: 846-54.
    • (2005) Eur Urol , vol.47 , pp. 846-854
    • Mirone, V.1    Costa, P.2    Damber, J.E.3    Holmes, S.4    Moncada, I.5    Van Ahlen, H.6
  • 4
    • 0036783940 scopus 로고    scopus 로고
    • Efficacy and safety of tadalafil for the treatment of erectile dysfunction: Results of integrated analyses
    • Brock GB, McMahon CG, Chen KK, Costigan T, Shen W, Watkins V, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: Results of integrated analyses. J Urol 2002; 168: 1332-6.
    • (2002) J Urol , vol.168 , pp. 1332-1336
    • Brock, G.B.1    McMahon, C.G.2    Chen, K.K.3    Costigan, T.4    Shen, W.5    Watkins, V.6
  • 5
    • 0036868441 scopus 로고    scopus 로고
    • Vardenafil for treatment of men with erectile dysfunction: Efficacy and safety in a randomized, double-blind, placebo-controlled trial
    • Hellstrom WJ, Gittelman M, Karlin G, Segerson T, Thibonnier M, Taylor T, et al. Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial. J Androl 2002; 23: 763-71.
    • (2002) J Androl , vol.23 , pp. 763-771
    • Hellstrom, W.J.1    Gittelman, M.2    Karlin, G.3    Segerson, T.4    Thibonnier, M.5    Taylor, T.6
  • 7
    • 27644499337 scopus 로고    scopus 로고
    • Treatment for erectile dysfunction based on patient-reported outcomes: To every man the PDE5 inhibitor that he finds superior
    • Hedelin H, Stroberg P. Treatment for erectile dysfunction based on patient-reported outcomes: To every man the PDE5 inhibitor that he finds superior. Drugs 2005; 65: 2245-51.
    • (2005) Drugs , vol.65 , pp. 2245-2251
    • Hedelin, H.1    Stroberg, P.2
  • 8
    • 0036589997 scopus 로고    scopus 로고
    • Patient choice is critical in managing erectile dysfunction
    • Heaton JP, Hackett G, Savage D, Padley RJ. Patient choice is critical in managing erectile dysfunction. Eur Urol 2002; 1 (Suppl 1): 33-7.
    • (2002) Eur Urol , vol.1 , Issue.SUPPL. 1 , pp. 33-37
    • Heaton, J.P.1    Hackett, G.2    Savage, D.3    Padley, R.J.4
  • 9
    • 29044448811 scopus 로고    scopus 로고
    • Evaluating preference trials of oral phosphodiesterase 5 inhibitors for erectile dysfunction
    • Mulhall JP, Montorsi F. Evaluating preference trials of oral phosphodiesterase 5 inhibitors for erectile dysfunction. Eur Urol 2006; 49: 30-7.
    • (2006) Eur Urol , vol.49 , pp. 30-37
    • Mulhall, J.P.1    Montorsi, F.2
  • 10
    • 31144472113 scopus 로고    scopus 로고
    • Treating erectile dysfunction by endothelial rehabilitation with phosphodiesterase 5 inhibitors
    • Sommer F, Schulze W. Treating erectile dysfunction by endothelial rehabilitation with phosphodiesterase 5 inhibitors. World J Urol 2005; 23: 385-92.
    • (2005) World J Urol , vol.23 , pp. 385-392
    • Sommer, F.1    Schulze, W.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.